Xuan Cao

机构：Taizhou Municipal Hospital, Taizhou University · ORCID：0000-0001-9713-4192

发表论文 70 篇 · 总被引 4565 次 · h-index 26

代表论文

• A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia (2024 · New England Journal of Medicine · 被引 50)
• Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission (2025 · Med · 被引 37)
• Piperlongumine conquers temozolomide chemoradiotherapy resistance to achieve immune cure in refractory glioblastoma via boosting oxidative stress-inflamation-CD8+-T cell immunity (2023 · Journal of Experimental & Clinical Cancer Research · 被引 30)
• Chemical Composition of Commercial Cannabis (2024 · Journal of Agricultural and Food Chemistry · 被引 27)
• ANGPTL4 influences the therapeutic response of patients with neovascular age-related macular degeneration by promoting choroidal neovascularization (2022 · JCI Insight · 被引 20)
• Blockade of DDR1/PYK2/ERK signaling suggesting SH2 superbinder as a novel autophagy inhibitor for pancreatic cancer (2023 · Cell Death and Disease · 被引 19)